Newsstand Menu

CSHL Stories and Media archive for Tag: RNA therapeutics

Image of a triple-negative breast cancer organoid

A new “link” to triple-negative breast cancer

6/30/2025

There’s no effective treatment for the deadly disease. A discovery by CSHL Professor David Spector and grad student Wenbo Xu could point to the first. Read the story »

Nature is trying to tell you something

2/3/2025

Former Cold Spring Harbor Laboratory scientist Richard Roberts won the Nobel Prize in 1993. Here, he recalls the “failure” that made him famous. Read the story »

Big clues emerge in small RNA mystery

12/16/2024

How does the body separate “self” from “nonself?” CSHL Professor Rob Martienssen uncovers fascinating new leads in plant pollen and mouse sperm. Read the story »

Lifesaving life science with Katalin Karikó

12/12/2024

Watch the 2023 Nobel laureate speak about her life’s work with acclaimed popular science author Carl Zimmer. Read the story »

2024 Double Helix Medal recipient Dr. Katalin Karikó

12/10/2024

She created the blueprint for mRNA vaccines. This year, Cold Spring Harbor Laboratory recognized her groundbreaking research and pioneering spirit. Watch the video »

image of Marilyn Simons, Bruce and Grace Stillman, Dr. Katalin Karikó, Daniel Doctoroff, and Alisa Doctoroff

19th annual Double Helix Medals dinner raises $7 million

11/15/2024

Cold Spring Harbor Laboratory’s annual gala honors Target ALS leaders Alisa and Daniel Doctoroff and Nobel laureate Dr. Katalin Karikó. Read the story »

Why some RNA drugs work better than others

3/6/2024

CSHL’s Justin Kinney and Spinraza inventor Adrian Krainer tested the newly approved SMA treatment, risdiplam, and another RNA therapeutic, branaplam. Read the story »

Adrian Krainer awarded honorary IADR membership

6/21/2023

Krainer was recognized for his pioneering research on spinal muscular atrophy and RNA therapeutics. Read the story »

Krainer named Society for RNA Therapeutics board member

4/18/2023

He helped pioneer the field. It changed medicine. Now, he joins a group of renowned scientists and physicians aiming to take it to the next level. Read the story »

From tragedy, a potential pediatric cancer treatment

4/12/2023

CSHL Professor Adrian Krainer, the man behind the “miracle drug” known as Spinraza®, has found a way to fight a deadly pediatric brain cancer in mice. Read the story »

A molecular machine’s secret weapon exposed

2/23/2023

A shape-shifter with a protruding arm and an appetite for unwanted RNA! CSHL biochemists identify the hidden talents of a mysterious molecule. Read the story »

A new treatment approach for cystic fibrosis

7/14/2022

Molecules called antisense oligonucleotides may help lung cells make a protein missing in people with cystic fibrosis. Read the story »

Image of dropper adding liquid to glass laboratory test tube

The promising drug duo that may improve SMA treatment

7/11/2022

Pairing Spinraza® with a second FDA-approved drug may be a new way to improve the drug’s therapeutic effects in spinal muscular atrophy patients. Read the story »

Krainer awarded Watanabe Prize in Translational Research

6/16/2022

Indiana University School of Medicine honored Krainer for his pioneering work on RNA splicing, which led to the first FDA-approved SMA therapeutic. Read the story »

Decoding how a protein on the move keeps cells healthy

5/31/2022

The Argonaute protein is a workhorse for cell regulation and CSHL researchers discovered what helps it commute from job to job. Read the story »

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.